142280 — Green Cross Medical Science Income Statement
0.000.00%
Last trade - 00:00- KR₩82bn
- KR₩101bn
- KR₩104bn
- 42
- 22
- 17
- 13
Annual income statement for Green Cross Medical Science, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 113,377 | 101,675 | 113,109 | 94,011 | 103,852 |
| Cost of Revenue | |||||
| Gross Profit | 19,818 | 1,673 | 12,805 | 14,025 | 14,852 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 109,179 | 121,839 | 114,372 | 92,210 | 102,256 |
| Operating Profit | 4,199 | -20,164 | -1,263 | 1,801 | 1,596 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 7,238 | -21,108 | -2,951 | 1,865 | 3,396 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 7,027 | -21,138 | -3,059 | 1,877 | 3,396 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | 6,717 | -21,202 | -3,581 | 1,797 | 3,581 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | 6,717 | -21,202 | -3,581 | 1,797 | 1,098 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 305 | -1,007 | -170 | 85.6 | 64.1 |
| Dividends per Share |